Evaluation of the Serum Markers sFLt1 and PlGF for the Prediction of the Complications of the Placental Vascular Pathologies in the 3rd Quarter of the Pregnancy.

Clinical trial NCT03455387 · COMPLETED

Trial details

NCT number: NCT03455387
Sponsor: Centre Hospitalier Metropole Savoie
Status: COMPLETED
Study type: OBSERVATIONAL

Pre-Eclampsia HELLP Syndrome Fetal Death Eclampsia Placental Abruption Fetal Growth Retardation, Antenatal

Start date: 2017-01-10
Primary completion: 2019-12-20
Enrollment: 233

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.